3-Year Post-Transcatheter Aortic Valve Replacement (TAVR) Restenosis: A Rare Complication

The pathophysiology of aortic valve stenosis is degenerative and calcific. It may be exacerbated by atherosclerotic processes characterized by lipid accumulation and inflammation. When the stenosis gets hemodynamically severe, the valves would need to be replaced. They could be replaced using mechan...

Full description

Saved in:
Bibliographic Details
Published in:Curēus (Palo Alto, CA) CA), 2024-02, Vol.16 (2), p.e53515
Main Authors: Orabueze, Ijeoma, Ogunleye, Olushola, Harrison, Mark
Format: Article
Language:English
Subjects:
Anticoagulants
Aortic stenosis
Blood clots
Calcification
Cardiac/Thoracic/Vascular Surgery
Cardiology
Endocarditis
Internal Medicine
Prostheses
Surgery
Thrombosis
Ultrasonic imaging
Velocity
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The pathophysiology of aortic valve stenosis is degenerative and calcific. It may be exacerbated by atherosclerotic processes characterized by lipid accumulation and inflammation. When the stenosis gets hemodynamically severe, the valves would need to be replaced. They could be replaced using mechanical or bioprosthetic heart valves. Balloon-expandable (BE) transcatheter heart valves (THVs) were compared to the self-expanding (SE) THVs and it was found that the rate of bioprosthetic valve failure was low over a five-year period. We present the case of a 70-year-old female who presented with worsening shortness of breath three years after transcatheter aortic valve replacement and was found to have early valve degeneration.
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.53515